FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

RM Brandt

Research Profile

Anatomy

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Sjoerd H van der burg; Kitty M C Kwappenberg; T O'Neill; RM Brandt; Cornelis J M Melief; Julian Hickling; Rienk Offringa
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens.
Maaike E Ressing; WJ van Driel; RM Brandt; Gemma G Kenter; J Hans De Jong; T Bauknecht; Gert Jan Fleuren; P Hoogerhout; Rienk Offringa; A Sette; E Celis; Howard Grey; Baptist J Trimbos; W Martin Kast; Cornelis J M Melief
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
WJ van Driel; Maaike E Ressing; Gemma G Kenter; RM Brandt; Eveline J T Krul; AB Van Rossum; Ed Schuuring; Rienk Offringa; T Bauknecht; A Tamm-Hermelink; P A van Dam; Gert Jan Fleuren; W Martin Kast; Cornelis J M Melief; J Baptist Trimbos
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of RM Brandt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Sjoerd H van der burg; Kitty M C Kwappenberg; T O'Neill; RM Brandt; Cornelis J M Melief; Julian Hickling; Rienk Offringa
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens.
Vaccine 2001;19(27):3652-60.
2000: Maaike E Ressing; WJ van Driel; RM Brandt; Gemma G Kenter; J Hans De Jong; T Bauknecht; Gert Jan Fleuren; P Hoogerhout; Rienk Offringa; A Sette; E Celis; Howard Grey; Baptist J Trimbos; W Martin Kast; Cornelis J M Melief
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(2):255-66.
1999: WJ van Driel; Maaike E Ressing; Gemma G Kenter; RM Brandt; Eveline J T Krul; AB Van Rossum; Ed Schuuring; Rienk Offringa; T Bauknecht; A Tamm-Hermelink; P A van Dam; Gert Jan Fleuren; W Martin Kast; Cornelis J M Melief; J Baptist Trimbos
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial.
European journal of cancer (Oxford, England : 1990) 1999;35(6):946-52.
1999: Maaike E Ressing; J Hans De Jong; RM Brandt; Jan Wouter Drijfhout; Willemien Benckhuijsen; G M Th Schreuder; Rienk Offringa; W Martin Kast; Cornelis J M Melief
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.
European journal of immunology 1999;29(4):1292-303.
1997: MJ Visseren; Sjoerd H van der burg; Ellen I H van der Voort; RM Brandt; Peter I Schrier; P van der Bruggen; T Boon; Cornelis J M Melief; W Martin Kast
Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.
International journal of cancer. Journal international du cancer 1997;73(1):125-30.
1997: E Ras; Sjoerd H van der burg; S T Zegveld; RM Brandt; Peter Kuppen; Rienk Offringa; S O Warnarr; C J van de Velde; Cornelis J M Melief
Identification of potential HLA-A *0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA).
Human immunology 1997;53(1):81-9.
1996: WJ van Driel; Maaike E Ressing; RM Brandt; René E M Toes; Gert Jan Fleuren; J B Trimbos; W Martin Kast; Cornelis J M Melief
The current status of therapeutic HPV vaccine.
Annals of medicine 1996;28(6):471-7.
1996: Koji Kono; Maaike E Ressing; RM Brandt; Cornelis J M Melief; Ronald K Potkul; B Andersson; M Petersson; W Martin Kast; Rolf Kiessling
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1825-8.
1996: Maaike E Ressing; R Offringa; René E M Toes; Ferry Ossendorp; J Hans De Jong; RM Brandt; W Martin Kast; Cornelis J M Melief
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity.
Immunotechnology : an international journal of immunological engineering 1996;2(4):241-51.
1996: Sjoerd H van der burg; M J Visseren; RM Brandt; W Martin Kast; Cornelis J M Melief
Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(9):3308-14.
1995: René E M Toes; M C Feltkamp; Maaike E Ressing; Michel P M Vierboom; R J Blom; RM Brandt; M Hartman; Rienk Offringa; Cornelis J M Melief; W Martin Kast
Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape.
Biochemical Society transactions 1995;23(3):692-6.
1995: Maaike E Ressing; Alessandro Sette; RM Brandt; J Ruppert; PA Wentworth; M Hartman; Carla Oseroff; Howard Grey; Cornelis J M Melief; W Martin Kast
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):5934-43.
1995: Joe D'Amaro; J G Houbiers; Jan Wouter Drijfhout; RM Brandt; R Schipper; J N Bavinck; Cornelis J M Melief; W Martin Kast
A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs.
Human immunology 1995;43(1):13-8.
1995: Jan Wouter Drijfhout; RM Brandt; Joe D'Amaro; W Martin Kast; Cornelis J M Melief
Detailed motifs for peptide binding to HLA-A*0201 derived from large random sets of peptides using a cellular binding assay.
Human immunology 1995;43(1):1-12.
1995: René E M Toes; Rienk Offringa; R J Blom; RM Brandt; A J van der Eb; Cornelis J M Melief; W Martin Kast
An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(7):3396-405.
1994: W Martin Kast; RM Brandt; J Sidney; Jan Wouter Drijfhout; R T Kubo; Howard Grey; Cornelis J M Melief; Alessandro Sette
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(8):3904-12.
1993: W Martin Kast; RM Brandt; Jan Wouter Drijfhout; Cornelis J M Melief
Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(2):115-20.